10,19-diethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;1-(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)-1-[1-[3-(1-formylpiperidin-4-yl)propyl]indol-5-yl]urea

C51H57N7O9 — CID 144807603

IUPAC10,19-diethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;1-(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)-1-[1-[3-(1-formylpiperidin-4-yl)propyl]indol-5-yl]urea
SMILESCCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)C3(CC)OC.[H]/N=C(\c1cc(C(C)C)c(O)cc1O)N(C(N)=O)c1ccc2c(ccn2CCCC2CCN(C=O)CC2)c1
InChIInChI=1S/C28H35N5O4.C23H22N2O5/c1-18(2)22-15-23(26(36)16-25(22)35)27(29)33(28(30)37)21-5-6-24-20(14-21)9-13-32(24)10-3-4-19-7-11-31(17-34)12-8-19;1-4-13-14-8-12(26)6-7-18(14)24-20-15(13)10-25-19(20)9-17-16(21(25)27)11-30-22(28)23(17,5-2)29-3/h5-6,9,13-19,29,35-36H,3-4,7-8,10-12H2,1-2H3,(H2,30,37);6-9,26H,4-5,10-11H2,1-3H3/b29-27+;
InChIKeyGNEPKTMJSLRDHQ-HEKQOYCRSA-N
MW912.06 g/mol
LogP7.74
Rot. Bonds11

About 10,19-diethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;1-(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)-1-[1-[3-(1-formylpiperidin-4-yl)propyl]indol-5-yl]urea

10,19-diethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;1-(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)-1-[1-[3-(1-formylpiperidin-4-yl)propyl]indol-5-yl]urea (PubChem CID 144807603) has the molecular formula C51H57N7O9 and a molecular weight of 912.06 g/mol. Its IUPAC name is 10,19-diethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;1-(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)-1-[1-[3-(1-formylpiperidin-4-yl)propyl]indol-5-yl]urea.

Molecular Properties

Compound Name10,19-diethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;1-(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)-1-[1-[3-(1-formylpiperidin-4-yl)propyl]indol-5-yl]urea
PubChem CID144807603
Molecular FormulaC51H57N7O9
Molecular Weight912.06 g/mol
Exact Mass911.42
IUPAC Name10,19-diethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;1-(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)-1-[1-[3-(1-formylpiperidin-4-yl)propyl]indol-5-yl]urea
SMILESCCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)C3(CC)OC.[H]/N=C(\c1cc(C(C)C)c(O)cc1O)N(C(N)=O)c1ccc2c(ccn2CCCC2CCN(C=O)CC2)c1
InChIInChI=1S/C28H35N5O4.C23H22N2O5/c1-18(2)22-15-23(26(36)16-25(22)35)27(29)33(28(30)37)21-5-6-24-20(14-21)9-13-32(24)10-3-4-19-7-11-31(17-34)12-8-19;1-4-13-14-8-12(26)6-7-18(14)24-20-15(13)10-25-19(20)9-17-16(21(25)27)11-30-22(28)23(17,5-2)29-3/h5-6,9,13-19,29,35-36H,3-4,7-8,10-12H2,1-2H3,(H2,30,37);6-9,26H,4-5,10-11H2,1-3H3/b29-27+;
InChIKeyGNEPKTMJSLRDHQ-HEKQOYCRSA-N
XLogP7.74
TPSA226.53 Ų
H-Bond Donors5
H-Bond Acceptors13
Rotatable Bonds11
Heavy Atoms67
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500912.06
LogP ≤ 57.74
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze 10,19-diethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;1-(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)-1-[1-[3-(1-formylpiperidin-4-yl)propyl]indol-5-yl]urea with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 10,19-diethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;1-(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)-1-[1-[3-(1-formylpiperidin-4-yl)propyl]indol-5-yl]urea?
The IUPAC name of 10,19-diethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;1-(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)-1-[1-[3-(1-formylpiperidin-4-yl)propyl]indol-5-yl]urea (CID 144807603) is 10,19-diethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;1-(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)-1-[1-[3-(1-formylpiperidin-4-yl)propyl]indol-5-yl]urea.
What is the SMILES notation for 10,19-diethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;1-(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)-1-[1-[3-(1-formylpiperidin-4-yl)propyl]indol-5-yl]urea?
The canonical SMILES for 10,19-diethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;1-(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)-1-[1-[3-(1-formylpiperidin-4-yl)propyl]indol-5-yl]urea is CCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)C3(CC)OC.[H]/N=C(\c1cc(C(C)C)c(O)cc1O)N(C(N)=O)c1ccc2c(ccn2CCCC2CCN(C=O)CC2)c1.
What is the InChIKey of 10,19-diethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;1-(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)-1-[1-[3-(1-formylpiperidin-4-yl)propyl]indol-5-yl]urea?
The InChIKey is GNEPKTMJSLRDHQ-HEKQOYCRSA-N. The full InChI is InChI=1S/C28H35N5O4.C23H22N2O5/c1-18(2)22-15-23(26(36)16-25(22)35)27(29)33(28(30)37)21-5-6-24-20(14-21)9-13-32(24)10-3-4-19-7-11-31(17-34)12-8-19;1-4-13-14-8-12(26)6-7-18(14)24-20-15(13)10-25-19(20)9-17-16(21(25)27)11-30-22(28)23(17,5-2)29-3/h5-6,9,13-19,29,35-36H,3-4,7-8,10-12H2,1-2H3,(H2,30,37);6-9,26H,4-5,10-11H2,1-3H3/b29-27+;.
What are the key properties of 10,19-diethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;1-(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)-1-[1-[3-(1-formylpiperidin-4-yl)propyl]indol-5-yl]urea?
10,19-diethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;1-(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)-1-[1-[3-(1-formylpiperidin-4-yl)propyl]indol-5-yl]urea has a molecular weight of 912.06 g/mol, XLogP of 7.74, 11 rotatable bonds, 5 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 10,19-diethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;1-(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)-1-[1-[3-(1-formylpiperidin-4-yl)propyl]indol-5-yl]urea is sourced from PubChem (CID 144807603), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).